Early Stage Company Valuation
Cogent Valuation provides early stage company valuation advisory services to early stage technology and life sciences companies, as well as to potential equity sponsors of such companies. Industry experience includes: software, Internet, computer hardware, networking, telecommunications, electronics, medical device, pharmaceutical and biotechnology. In addition to valuation and fairness opinions, Cogent Valuation advises clients regarding pricing, security and transaction structure, business plan assessment and performs due diligence reviews.
Since early stage companies generally lack meaningful and sustainable earnings and cash flow, their valuation proves inherently more difficult than that of mature companies. To address this, Cogent Valuation utilizes proprietary studies and innovative methodologies to value early stage companies.
Cogent Valuation/VentureOne Study
The Pricing of Successful Capital Backed High Tech and Life Sciences Companies